Skip to Content

PrimeMune Vaccine

This page contains information on PrimeMune Vaccine for veterinary use.
The information provided typically includes the following:
  • PrimeMune Vaccine Indications
  • Warnings and cautions for PrimeMune Vaccine
  • Direction and dosage information for PrimeMune Vaccine

PrimeMune Vaccine

This treatment applies to the following species:
Manufacturer: Bimeda

Canine Distemper - Adenovirus Type 2 - Parainfluenza - Parvovirus Vaccine, Modified Live Virus

Modified live vaccine against canine distemper (CDV), adenovirus Type 2 (CAV-2), parvovirus (CPV-2), parainfluenza (CPIV-2) in dogs.

Restricted to use by a veterinarian

Composition - 1 mL:

a) FREEZE-DRIED COMPONENTS:

Distemper

Adenovirus Type 2

Parvovirus

Parainfluenza

b) DILUENT: Water for Injection

DRUG FORM: Freeze-dried injection.

IMMUNOLOGICAL PROPERTIES: After being injected into the body of the vaccinated individual, the antigens present in the vaccine are recognized as extraneous elements and a number of defensive mechanisms in the body are activated (macrophages, opsonins, inierleukins, B lymphocytes, etc.), in consequence of which specific antibodies against the antigen determinants contained in the vaccine start to form. The said mechanisms shall prevent from subsequent development of the infection after contagion.

TARGET SPECIES: Dogs.

WITHDRAWAL PERIODS: Not intended for food animals.

INDICATION: For subcutaneous vaccination of healthy dogs for prevention of disease caused by canine distemper virus, canine adenovirus Type-2 and as an aid in the prevention of disease caused by canine parainfluenza virus and canine parvovirus.

Minimum age for vaccination - 6 weeks, revaccinate at 3-4 week intervals until the dog is 12 weeks of age. Annual revaccination with one dose is recommended.

CONTRAINDICATION: Total pyrexial disease.

INTERACTION: No information is available on the compatibility of this vaccine with any other vaccine.

RECOMMENDED VACCINATION SCHEME: See above.

CANINE AGE: 6-16 weeks.

ANNUAL REVACCINATION: The vaccination scheme should be specified by the veterinarian depending on the infection situation and the level of the passive immunity obtained due to antibodies in the vaccinated individuals. Annual revaccination is recommended to maintain permanent immunity.

SPECIAL PRECAUTIONS FOR USE: Only clinically healthy animals in a good nutrition condition should be vaccinated. Possible anti-parasitic treatment should be carried out at least 10 days before the vaccination. The vaccinated animals should not be trained or exercised for one week after the vaccination.

When diluted, the vaccine shall be used immediately.

DOSAGE AND ROUTE OF ADMINISTRATION: The dose is 1 mL regardless of age, weight and breed of the individual, vaccination may be first performed during the sixth week of age.

Route of administration - subcutaneously, preferably in zone behind the shoulder blade.

ADVERSE EFFECTS: None known.

PACKAGE:

Plastic box - 10 x 1 mL of vaccine and 10x1 mL of sterile diluent or

The package insert is attached to each package.

Storage

Store in a dry and dark place between 2-7°C. Do not use after the expiry date stated on the label. When diluted, the vaccine shall be used immediately.

SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY:

The packages and any remainders of the preparation are to be disposed of pursuant to the regulations in force. Burn the container and all unused contents.

Manufactured by: Bioveta, a.s., Komenského 212, Ivanovice na Hané, Czech Republic

Produced for: Aceto Pharma Carp., 4 Tri Harbor Court, Port Washington, NY, USA

U.S. Permit No. 594A

Distributed exclusively in the USA by: Bimeda, Inc., One Tower Lane, Suite 2250, Oakbrook Terrace, IL, USA

™ Trademark of Bimeda, Inc.

Date of the last text revision: April, 2011

 

Product Code

10 x 1 mL Vials of Vaccine

10 x 1 mL Vials of Diluent

1PRI001

NAC No.: 13991000

BIMEDA, INC.
Div. Cross Vetpharm Group, Ltd.

ONE TOWER LANE-SUITE 2250, OAKBROOK TERRACE, IL, 60181
Telephone:   630-928-0361
Fax:   630-928-0362
Website:   www.bimedaus.com
Email:   sales@bimedaus.com
Every effort has been made to ensure the accuracy of the PrimeMune Vaccine information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2016 North American Compendiums. Updated: 2016-08-21

Hide